Marinomed Biotech AG
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
MARI | VI
Overview
Corporate Details
- ISIN(s):
- ATMARINOMED6
- LEI:
- 529900GN3B1EN80XF405
- Country:
- Austria
- Address:
- Hovengasse 25, 2100 Korneuburg
- Website:
- https://www.marinomed.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Marinomed Biotech AG is a science-based biopharmaceutical company that develops innovative therapies for diseases in virology and immunology. The company leverages two proprietary technology platforms: Carragelose®, a virus-blocking compound used in globally marketed nasal sprays and lozenges, and Marinosolv®, a technology platform that enhances the solubility of poorly soluble compounds to develop new treatments for various immunological conditions. Marinomed's business model encompasses in-house development of medicinal products and medical devices, as well as strategic partnerships to commercialize its pipeline and technologies. The company focuses on addressing conditions with limited or no effective treatment options, particularly in respiratory and autoreactive immune disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-31 10:01 |
Declaration of Voting Results & Voting Rights Announcements
EQS-NVR: Marinomed Biotech AG: Release according to Article 135, Section 1 Börs…
|
English | 16.5 KB | ||
| 2025-10-31 10:01 |
Declaration of Voting Results & Voting Rights Announcements
EQS-NVR: Marinomed Biotech AG: Veröffentlichung der Gesamtstimmrechte nach § 13…
|
German | 17.0 KB | ||
| 2025-10-31 10:00 |
Declaration of Voting Results & Voting Rights Announcements
Release according to Article 135, Section 1 BorseG with the objective of Europe…
|
English | 3.6 KB | ||
| 2025-10-06 14:58 |
Regulatory News Service
EQS-Adhoc: Marinomed Biotech AG begins reviewing strategic options for the Mari…
|
English | 34.6 KB | ||
| 2025-10-06 14:58 |
M&A Activity
EQS-Adhoc: Marinomed Biotech AG startet Prüfung strategischer Optionen für die …
|
German | 36.4 KB | ||
| 2025-10-06 14:56 |
Regulatory News Service
Marinomed Biotech AG begins reviewing strategic options for the Marinosolv plat…
|
English | 11.1 KB | ||
| 2025-09-17 13:48 |
Earnings Release
Marinomed Biotech AG announces results for the first half year of 2025
|
English | 10.6 KB | ||
| 2025-09-17 13:42 |
Interim Report
EQS-AFR: Marinomed Biotech AG: Release of a Financial report
|
English | 3.4 MB | ||
| 2025-09-17 13:42 |
Interim Report
EQS-AFR: Marinomed Biotech AG: Bekanntmachung über die Veröffentlichung eines F…
|
German | 3.5 MB | ||
| 2025-09-16 15:24 |
Share Issue/Capital Change
EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory s…
|
English | 31.7 KB | ||
| 2025-09-16 15:24 |
Share Issue/Capital Change
EQS-Adhoc: Marinomed Biotech AG beschließt Kapitalerhöhung unter Bezugsrechtsau…
|
German | 33.7 KB | ||
| 2025-09-16 15:22 |
Share Issue/Capital Change
Marinomed Biotech AG resolves capital increase excluding statutory subscription…
|
English | 8.0 KB | ||
| 2025-09-02 09:18 |
Pre-Annual General Meeting Information
EQS-AGM: Marinomed Biotech AG: Convening of an Extraordinary General Meeting fo…
|
English | 51.6 KB | ||
| 2025-09-02 09:17 |
Pre-Annual General Meeting Information
EQS-HV: Marinomed Biotech AG: Einberufung einer außerordentlichen Hauptversamml…
|
German | 50.1 KB | ||
| 2025-09-02 09:16 |
Pre-Annual General Meeting Information
Marinomed Biotech AG: Convening of an Extraordinary General Meeting for Tuesday…
|
English | 21.9 KB |
Automate Your Workflow. Get a real-time feed of all Marinomed Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Marinomed Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Marinomed Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
